首页|醒脑静联合前列地尔对急性缺血性脑卒中患者再灌注后脑保护作用

醒脑静联合前列地尔对急性缺血性脑卒中患者再灌注后脑保护作用

扫码查看
目的 研究醒脑静联合前列地尔对急性缺血性脑卒中患者再灌注后脑的保护作用.方法 选择浙江新安国际医院急诊科2014年3月~2016年3月收治的60例急性缺血性脑卒中再灌注患者作为研究对象,将其随机分为对照组和治疗组,每组各30例.对照组接受常规治疗加用前列地尔,治疗组在对照组基础上联合醒脑静治疗.2组患者经治疗后,均给予护理干预,如常规饮食指导、营养支持、健康教育等.将2组治疗后的神经系统功能评分情况和血清氧化应激指标(MDA、Hcy)、血管内皮生长因子(VEGF)水平进行对比,同时记录2组治疗前后脑血流灌注量(CBFV),并观察治疗过程中的不良反应.结果 治疗14 d后,治疗组NIHSS评分低于对照组,ADL评分均高于对照组,2组间比较差异具有统计学意义(P<0.05);治疗前,2组氧化应激指标MDA、Hcy水平对比无统计学意义,治疗后,治疗组2指标水平明显较对照组降低(P<0.05);治疗前,2组VEGF、CBFV水平对比无统计学意义,治疗后,治疗组VEGF、CBFV水平均明显较对照组提升(P<0.05);2组间不良反应率相似,且无明显严重不良反应,2组间比较差异无统计学意义.结论 醒脑静联合前列地尔对急性缺血性脑卒中有一定的临床疗效,对再灌注后脑组织起到了良好的保护作用.
Protective effect of Xingnaojing combined with alprostadil on cerebral ischemia in patients with acute ischemic stroke
Objective To study the protective effect of Xingnaojing combined with alprostadil on brain after acute ischemic stroke in rats.MethodsSixty patients with acute ischemic stroke were enrolled in zhejiang xin'an international hospital from March 2014 to March 2016.They were randomly divided into control group and treatment group, 30 cases in each group.The control group received conventional treatment plus alprostadil, the treatment group in the control group based on the combination of Xingnaojing treatment.Two groups of patients after treatment, are given nursing intervention, such as routine diet guidance, nutritional support, health education.The levels of serum oxidative stress (MDA), vascular endothelial growth factor (VEGF) and vascular endothelial growth factor (VEGF) were compared between the two groups before and after treatment.The levels of cerebral blood flow (CBFV) were recorded before and after treatment Observe the adverse reactions during treatment.ResultsAfter 14 days of treatment, the NIHSS score of the treatment group was lower than that of the control group and the ADL score was higher than that of the control group.The difference between the two groups was statistically significant (P<0.05).Before treatment, the oxidative stress indexes MDA and Hcy were no significant difference between the two groups.After treatment, the oxidative stress indexes MDA and Hcy were lower than the control group(P<0.05).Before treatment, the levels of VEGF and CBFV in the two groups were no significant difference between the two groups.After treatment, the levels of VEGF and CBFV in the two groups were significantly higher than those in the control group (P<0.05).The adverse reaction rate between the 2 groups was similar, and there was no significant adverse reaction, there was no significant difference between the two groups.ConclusionXingnaojing combined with alprostadil has a certain clinical effect on acute ischemic stroke, and has a good protective effect on brain tissue after reperfusion.

xingnaojingalprostadilacute ischemic strokereperfusionbrain protection

杜雅明、刘红军、许锋杰、余五珍

展开 >

浙江新安国际医院急诊科,浙江嘉兴314000

醒脑静 前列地尔 急性缺血性脑卒中 再灌注 脑保护

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(5)
  • 6
  • 13